Avience Biomedicals (NSE:AVIENCE) EPS without NRI: ₹0.00 (TTM As of Jan. 2026)


NSE:AVIENCE Avience Biomedicals Ltd NSE:AVIENCE
5 GF Score
Price ₹414.95
View Full Analysis

What is Avience Biomedicals EPS without NRI?

Avience Biomedicals NSE:AVIENCE 5 EPS without NRI is ₹0.00 as of Jan. 2026. GuruFocus rates NSE:AVIENCE with a GF Score™ of 5/100. Among 666 Medical Devices & Instruments companies, Avience Biomedicals ranks worse than 150150% on this metric.

Avience Biomedicals's earnings per share without non-recurring items for the three months ended in Jan. 2026 was ₹0.00. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jan. 2026 was ₹0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Avience Biomedicals's EPS without NRI or its related term are showing as below:

NSE:AVIENCE's 3-Year EPS without NRI Growth Rate is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 8.15
* Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.

Avience Biomedicals's EPS (Diluted) for the three months ended in Jan. 2026 was ₹0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jan. 2026 was ₹0.00.

Avience Biomedicals's EPS (Basic) for the three months ended in Jan. 2026 was ₹0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jan. 2026 was ₹0.00.


Avience Biomedicals  (NSE:AVIENCE) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Avience Biomedicals EPS without NRI Related Terms


Avience Biomedicals EPS without NRI Historical Data

* Premium members only.

The historical data trend for Avience Biomedicals's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avience Biomedicals EPS without NRI Chart

Avience Biomedicals Annual Data
Trend Mar23 Mar24 Mar25
EPS without NRI
1.29 3.87 13.07

Avience Biomedicals Quarterly Data
Mar23 Mar24 Mar25 Jan26
EPS without NRI 0.00 0.00 0.00 0.00

NSE:AVIENCE vs ABT, SYK, MDT: EPS without NRI Comparison

For the Medical Devices subindustry, Avience Biomedicals's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avience Biomedicals PE Ratio without NRI vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Avience Biomedicals's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Avience Biomedicals's PE Ratio without NRI falls into.


NSE:AVIENCE
5GF Score
Avience Biomedicals Ltd NSE:AVIENCE
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Avience Biomedicals EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of ₹0.00 mean?
Avience Biomedicals (NSE:AVIENCE) has a EPS without NRI of ₹0.00 as of Jan. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Avience Biomedicals and its competitors. According to the industry distribution chart, Avience Biomedicals ranks #999999 out of 666 companies in the Medical Devices & Instruments industry.
Is Avience Biomedicals' EPS without NRI too high?
Avience Biomedicals' current EPS without NRI is ₹0.00. Based on the distribution chart, Avience Biomedicals ranks #999999 out of 666 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Avience Biomedicals has a GF Score™ of 5/100, reflecting its overall financial health beyond just this single metric.
How does Avience Biomedicals' EPS without NRI compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Avience Biomedicals ranks #999999 out of 666 companies for EPS without NRI. This places Avience Biomedicals in the lower half of its industry. The industry median EPS without NRI is 8.15. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Devices & Instruments company?
The median EPS without NRI among Medical Devices & Instruments companies is 8.15, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Avience Biomedicals and its competitors. For the Medical Devices & Instruments industry, the median EPS without NRI is 8.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avience Biomedicals's current EPS without NRI is ₹0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avience Biomedicals stock overvalued right now?
Avience Biomedicals (NSE:AVIENCE) has a current EPS without NRI of ₹0.00. The current EPS without NRI is ₹0.00. Avience Biomedicals' overall GF Score™ is 5/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Avience Biomedicals (NSE:AVIENCE), the current EPS without NRI is ₹0.00 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avience Biomedicals Business Description

Address C-11, Block-C, Community Centre, Unit No-2, 1st Floor, Janakpuri A-3, New Delhi, IND, 110058
Avience Biomedicals Ltd is a medical consumables company focused on the manufacturing of Vitro-Diagnostic (IVD) products and medical devices. Its product offerings include diagnostic solutions used for the detection of diseases, conditions, and infections across laboratory, healthcare, and home-use applications. The company operates in areas including molecular biotechnology, genomics, and diagnostic products, and also provides distribution services for medical technology products in India. Its revenue is generated from Manufactured Goods and Traded Goods and Services, which include the sale of Medical Devices and Consumables.
5GF Score

Get the complete analysis for NSE:AVIENCE

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹414.95
Price